Search

Your search keyword '"Albaladejo, Pierre"' showing total 654 results
Start Over Author "Albaladejo, Pierre"
654 results on '"Albaladejo, Pierre"'

7. Tenue vestimentaire au bloc opératoire 2021

Author

Hafiani, El-Mahdi, Cassier, Pierre, Aho, Serge, Albaladejo, Pierre, Beloeil, Hélène, Boudot, Evelyne, Carenco, Philippe, Lallemant, Florence, Leroy, Marie Gabrielle, Muret, Jane, Tamames, Corinne, and Garnier, Marc

Published
2022
Full Text
View/download PDF

10. Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

Author

Milling, Truman J., Jr, Middeldorp, Saskia, Xu, Lizhen, Koch, Bruce, Demchuk, Andrew, Eikelboom, John W., Verhamme, Peter, Cohen, Alexander T., Beyer-Westendorf, Jan, Michael Gibson, C., Lopez-Sendon, Jose, Crowther, Mark, Shoamanesh, Ashkan, Coppens, Michiel, Schmidt, Jeannot, Albaladejo, Pierre, Connolly, Stuart J., Anand, R., Bastani, A., Clark, C., Concha, M., Cornell, J., Dombrowski, K., Fermann, G., Fulmer, J., Goldstein, J., Kereiakes, D., Milling, T., Pallin, D., Patel, N., Refaai, M., Rehman, M., Schmaier, A., Schwarz, E., Shillinglaw, W., Spohn, M., Takata, T., Venkat, A., Welker, J., Welsby, I., Wilson, J., Van Keer, L., Verschuren, F., Blostein, M., Eikelboom, J., Althaus, K., Berrouschot, J., Braun, G., Doeppner, T., Dziewas, R., Genth-Zotz, S., Greinacher, P., Hamann, F., Hanses, F., Heide, W., Kallmuenzer, B., Kermer, P., Poli, S., Royl, G., Schellong, S., Schnupp, S., Schwarze, J., Spies, C., Thomalla, G., von Mering, M., Weissenborn, K., Wollenweber, F., Gumbinger, C., Jaschinski, U., Maschke, M., Mochmann, H-C., Pfeilschifter, W., Pohlmann, C., Zahn, R., Bouzat, P., Schmidt, J., Vallejo, C., Floccard, B., Coppens, M., van Wissen, S., Arellano-Rodrigo, E., Valles, E., Alikhan, R., Breen, K., Hall, R., Crowther, M., Albaladejo, P., Cohen, A., Demchuk, A.M., Schmidt, J., Wyse, D.G., Garcia, D.A., Prins, M., Nakamya, J., Büller, H.R., Mahaffey, K. W., Alexander, J. H., Cairns, J.A., Hart, R.G., Joyner, C.D., Raskob, G.E., Schulman, S., Veltkamp, R., Meeks, B., Zotova, E., Ahmad, S., Pinto, T., Baker, K., Dykstra, A., Holadyk-Gris, I., Malvaso, A., and Demchuk, A.M.

Published
2023
Full Text
View/download PDF

11. Impact of a large interprofessional simulation-based training course on communication, teamwork, and safety culture in the operating theatre: A mixed-methods interventional study

Author

Picard, Julien, Evain, Jean-Noël, Douron, Charlène, Maussion, Éloïse, Stihle, Xavier, Manhes, Pauline, Romegoux, Pauline, Baron, Aline, Chapuis, Claire, Vermorel, Céline, Garel, Benjamin, Faucheron, Jean-Luc, Bouzat, Pierre, Bosson, Jean-Luc, and Albaladejo, Pierre

Published
2022
Full Text
View/download PDF

12. Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT)

Author

Godon, Alexandre, Tacquard, Charles Ambroise, Mansour, Alexandre, Garrigue, Delphine, Nguyen, Philippe, Lasne, Dominique, Testa, Sophie, Levy, Jerrold H., Albaladejo, Pierre, Gruel, Yves, Susen, Sophie, Godier, Anne, le GIHP, pour, and GFHT, le

Published
2021
Full Text
View/download PDF

13. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)

Author

Albaladejo, P., Blais, N., Bonhomme, F., Borel-Derlon, A., Cohen, A., Collet, J.-P., de Maistre, E., Fontana, P., Garrigue Huet, D., Godier, A., Gruel, Y., Godon, A., Ickx, B., Laporte, S., Lasne, D., Llau, J., Le Gal, G., Lecompte, T., Lessire, S., Levy, J.H., Longrois, D., Madi-Jebara, S., Mansour, A., Mazighi, M., Mismetti, P., Morange, P.E., Motte, S., Mullier, F., Nathan, N., Nguyen, P., Pernod, G., Rosencher, N., Roullet, S., Roy, P.M., Schlumberger, S., Sié, P., Steib, A., Susen, S., Tacquard, C.A., Testa, S., Vincentelli, A., Zufferey, P., Boissier, E, Dumont, B, James, C, Siguret, V., Godon, Alexandre, Tacquard, Charles Ambroise, Mansour, Alexandre, Garrigue, Delphine, Nguyen, Philippe, Lasne, Dominique, Testa, Sophie, Levy, Jerrold H., Albaladejo, Pierre, Gruel, Yves, Susen, Sophie, and Godier, Anne

Published
2021
Full Text
View/download PDF

19. Diagnosis and management of heparin-induced thrombocytopenia

Author

Albaladejo, P., Belisle, S., Blais, N., Bonhomme, F., Borel-Derlon, A., Borg, J.Y., Bosson, J.-L., Cohen, A., Collet, J.-P., de Maistre, E., Faraoni, D., Fontana, P., Huet, D. Garrigue, Godier, A., Gruel, Y., Guay, J., Hardy, J.F., Huet, Y., Ickx, B., Laporte, S., Lasne, D., Levy, J.H., Llau, J., Le Gal, G., Lecompte, T., Lessire, S., Longrois, D., Madi-Jebara, S., Marret, E., Mas, J.L., Mazighi, M., Meyer, G., Mismetti, P., Morange, P.E., Motte, S., Mullier, F., Nathan, N., Nguyen, P., Ozier, Y., Pernod, G., Rosencher, N., Roullet, S., Roy, P.M., Samama, C.M., Schlumberger, S., Schved, J.F., Sié, P., Steib, A., Susen, S., Testa, S., van Belle, E., van Der Linden, P., Vincentelli, A., Zufferey, P., Gruel, Yves, De Maistre, Emmanuel, Pouplard, Claire, Mullier, François, Susen, Sophie, Roullet, Stéphanie, Blais, Normand, Le Gal, Grégoire, Vincentelli, André, Lasne, Dominique, Lecompte, Thomas, Albaladejo, Pierre, and Godier, Anne

Published
2020
Full Text
View/download PDF

21. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

Author

Connolly, Stuart J, Milling, Truman J, Eikelboom, John W, Gibson, C Michael, Curnutte, John T, Gold, Alex, Bronson, Michele D, Lu, Genmin, Conley, Pamela B, Verhamme, Peter, Schmidt, Jeannot, Middeldorp, Saskia, Cohen, Alexander T, Beyer-Westendorf, Jan, Albaladejo, Pierre, Lopez-Sendon, Jose, Goodman, Shelly, Leeds, Janet, Wiens, Brian L, Siegal, Deborah M, Zotova, Elena, Meeks, Brandi, Nakamya, Juliet, Lim, W Ting, and Crowther, Mark

Subjects
Hematology, Clinical Research, Cardiovascular, Acute Disease, Aged, Aged, 80 and over, Cardiovascular Diseases, Enoxaparin, Factor Xa, Factor Xa Inhibitors, Female, Gastrointestinal Hemorrhage, Hemorrhage, Humans, Infusions, Intravenous, Intracranial Hemorrhages, Male, Prospective Studies, Pyrazoles, Pyridones, Recombinant Proteins, Rivaroxaban, Thrombosis, ANNEXA-4 Investigators, Medical and Health Sciences, General & Internal Medicine
Abstract

BackgroundAndexanet alfa (andexanet) is a recombinant modified human factor Xa decoy protein that has been shown to reverse the inhibition of factor Xa in healthy volunteers.MethodsIn this multicenter, prospective, open-label, single-group study, we evaluated 67 patients who had acute major bleeding within 18 hours after the administration of a factor Xa inhibitor. The patients all received a bolus of andexanet followed by a 2-hour infusion of the drug. Patients were evaluated for changes in measures of anti-factor Xa activity and were assessed for clinical hemostatic efficacy during a 12-hour period. All the patients were subsequently followed for 30 days. The efficacy population of 47 patients had a baseline value for anti-factor Xa activity of at least 75 ng per milliliter (or ≥0.5 IU per milliliter for those receiving enoxaparin) and had confirmed bleeding severity at adjudication.ResultsThe mean age of the patients was 77 years; most of the patients had substantial cardiovascular disease. Bleeding was predominantly gastrointestinal or intracranial. The mean (±SD) time from emergency department presentation to the administration of the andexanet bolus was 4.8±1.8 hours. After the bolus administration, the median anti-factor Xa activity decreased by 89% (95% confidence interval [CI], 58 to 94) from baseline among patients receiving rivaroxaban and by 93% (95% CI, 87 to 94) among patients receiving apixaban. These levels remained similar during the 2-hour infusion. Four hours after the end of the infusion, there was a relative decrease from baseline of 39% in the measure of anti-factor Xa activity among patients receiving rivaroxaban and of 30% among those receiving apixaban. Twelve hours after the andexanet infusion, clinical hemostasis was adjudicated as excellent or good in 37 of 47 patients in the efficacy analysis (79%; 95% CI, 64 to 89). Thrombotic events occurred in 12 of 67 patients (18%) during the 30-day follow-up.ConclusionsOn the basis of a descriptive preliminary analysis, an initial bolus and subsequent 2-hour infusion of andexanet substantially reduced anti-factor Xa activity in patients with acute major bleeding associated with factor Xa inhibitors, with effective hemostasis occurring in 79%. (Funded by Portola Pharmaceuticals; ANNEXA-4 ClinicalTrials.gov number, NCT02329327 .).

Published
2016

24. Médecine périopératoire : l’anesthésiste-réanimateur, un acteur majeur du pronostic

Author

Paugam-Burtz, Catherine, Albaladejo, Pierre, Asehnoune, Karim, Beloeil, Hélène, Benhamou, Dan, Capdevila, Mathieu, Capdevila, Xavier, Constantin, Jean-Michel, De Jong, Audrey, Ferré, Fabrice, Futier, Emmanuel, Jaber, Samir, Joannes-Boyau, Olivier, Labaste, François, Legrand, Matthieu, Maurice-Szamburski, Axel, Minville, Vincent, Roquilly, Antoine, and Samii, Kamran

Published
2019
Full Text
View/download PDF

27. Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)

Author

Belisle, S., Blais, N., Borel-Derlon, A., Borg, J.Y., Bosson, J.-L., Cohen, A., Faraoni, D., Garrigue Huet, D., Guay, J., Hardy, J.F., Huet, Y., Laporte, S., Levy, J.H., Llau, J., Le Gal, G., Lessire, S., Longrois, D., Madi-Jebara, S., Marret, E., Mas, J.L., Meyer, G., Mismetti, P., Morange, P.E., Motte, S., Mullier, F., Nathan, N., Ozier, Y., Pernod, G., Rosencher, N., Roullet, S., Roy, P.M., Samama, C.M., Schlumberger, S., Schved, J.F., Sié, P., Steib, A., Susen, S., van Belle, E., van Der Linden, P., Zufferey, P., Godier, Anne, Garrigue, Delphine, Lasne, Dominique, Fontana, Pierre, Bonhomme, Fanny, Collet, Jean-Philippe, de Maistre, Emmanuel, Ickx, Brigitte, Gruel, Yves, Mazighi, Mikael, Nguyen, Philippe, Vincentelli, André, Albaladejo, Pierre, and Lecompte, Thomas

Published
2019
Full Text
View/download PDF

29. Strategic proposal for a national trauma system in France

Author

Gauss, Tobias, Balandraud, Paul, Frandon, Julien, Abba, Julio, Ageron, Francois Xavier, Albaladejo, Pierre, Arvieux, Catherine, Barbois, Sandrine, Bijok, Benjamin, Bobbia, Xavier, Charbit, Jonathan, Cook, Fabrice, David, Jean-Stephane, Maurice, Guillaume De Saint, Duranteau, Jacques, Garrigue, Delphine, Gay, Emmanuel, Geeraerts, Thomas, Ghelfi, Julien, Hamada, Sophie, Harrois, Anatole, Kobeiter, Hicham, Leone, Marc, Levrat, Albrice, Mirek, Sebastien, Nadji, Abdel, Paugam-Burtz, Catherine, Payen, Jean Francois, Perbet, Sebastien, Pirracchio, Romain, Plenier, Isabelle, Pottecher, Julien, Rigal, Sylvain, Riou, Bruno, Savary, Dominique, Secheresse, Thierry, Tazarourte, Karim, Thony, Frederic, Tonetti, Jerome, Tresallet, Christophe, Wey, Pierre-Francois, Picard, Julien, and Bouzat, Pierre

Published
2019
Full Text
View/download PDF

30. Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and Intensive Care (SFAR)

Author

Godier, Anne, Garrigue, Dephine, Lasne, Dominique, Fontana, Pierre, Bonhomme, Fanny, Collet, Jean-Philippe, de Maistre, Emmanuel, Ickx, Brigitte, Gruel, Yves, Mazighi, Mikael, Nguyen, Philippe, Vincentelli, André, Albaladejo, Pierre, and Lecompte, Thomas

Published
2019
Full Text
View/download PDF

31. Diaphragm thickness modifications and associated factors during VA-ECMO for a cardiogenic shock: a cohort study.

Author

Moury, Pierre-Henri, Béhouche, Alexandre, Bailly, Sébastien, Durand, Zoé, Dessertaine, Géraldine, Pollet, Angelina, Jaber, Samir, Verges, Samuel, and Albaladejo, Pierre

Subjects
CARDIOGENIC shock, DIAPHRAGM (Anatomy), EXTRACORPOREAL membrane oxygenation, RESEARCH funding, SCIENTIFIC observation, HEART assist devices, FISHER exact test, DESCRIPTIVE statistics, LONGITUDINAL method, ODDS ratio, EXTUBATION, CONFIDENCE intervals, VENTILATOR weaning, DATA analysis software, REGRESSION analysis
Abstract

Background: The incidence, causes and impact of diaphragm thickness evolution in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock are unknown. Our study investigates its evolution during the first week of VA-ECMO and its relationship with sweep gas flow settings. Methods: We conducted a prospective monocentric observational study in a 12-bed ICU in France, enrolling patients on the day of the VA-ECMO implantation. The diaphragm thickness and the diaphragm thickening fraction (as index of contractile activity, dTF; dTF < 20% defined a low contractile activity) were daily measured for one week using ultrasound. Factors associated with diaphragm thickness evolution (categorized as increased, stable, or atrophic based on > 10% modification from baseline to the last measurement), early extubation role (< day4), and patients outcome at 60 days were investigated. Changes in diaphragm thickness, the primary endpoint, was analysed using a mixed-effect linear model (MLM). Results: Of the 29 included patients, seven (23%) presented diaphragm atrophy, 18 remained stable (60%) and 4 exhibited an increase (17%). None of the 13 early-extubated patients experienced diaphragm atrophy, while 7 (46%) presented a decrease when extubated later (p-value = 0.008). Diaphragm thickness changes were not associated with the dTF (p-value = 0.13) but with sweep gas flow (Beta = − 3; Confidence Interval at 95% (CI) [− 4.8; − 1.2]. p-value = 0.001) and pH (Beta = − 2; CI [− 2.9; − 1]. p-value < 0.001) in MLM. The dTF remained low (< 20%) in 20 patients (69%) at the study's end and was associated with sweep gas flow evolution in MLM (Beta = − 2.8; 95% CI [− 5.2; − 0.5], p-value = 0.017). Odds ratio of death at 60 days in case of diaphragm atrophy by day 7 was 8.50 ([1.4–74], p = 0.029). Conclusion: In our study, diaphragm thickness evolution was frequent and not associated with the diaphragm thickening fraction. Diaphragm was preserved from atrophy in case of early extubation with ongoing VA-ECMO assistance. Metabolic disorders resulting from organ failures and sweep gas flow were linked with diaphragm thickness evolution. Preserved diaphragm thickness in VA-ECMO survivors emphasizes the importance of diaphragm-protective strategies, including meticulous sweep gas flow titration. Key points: Question: How does the diaphragm thickness evolves during the first week of VA-ECMO treatment for a cardiogenic shock and is it associated with sweep gas flow settings? Findings: In patient receiving VA-ECMO for a cardiogenic shock, fewer progressive atrophy was described when early extubation was possible and associated with lower death rate at two months. The diaphragm thickness increased with the sweep gas flow and decreased with the acidosis. Diaphragm thickness evolution did not evolve parallel to the diaphragm thickening fraction. Meaning: In VA-ECMO-treated patients, we advocate for diaphragmatic-protective strategies through the careful titration of sweep gas flows, tight pH control, and the promotion of early extubation. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

32. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?

Author

Albaladejo, Pierre, Belisle, Sylvain, Blais, Normand, Bonhomme, Fanny, Borel-Derlon, Annie, Borg, Jeanne-Yvonne, Bosson, Jean-Luc, Cohen, Ariel, Collet, Jean-Philippe, de Maistre, Emmanuel, Faraoni, David, Fontana, Pierre, Garrigue Huet, Delphine, Godier, Anne, Gruel, Yves, Guay, Joanne, Hardy, Jean-François, Huet, Yann, Ickx, Brigitte, Laporte, Silvy, Lasne, Dominique, Levy, Jerrold H., Llau, Juan, Le Gal, Grégoire, Lecompte, Thomas, Lessire, Sarah, Longrois, Dan, Madi-Jebara, Samia, Marret, Emmanuel, Mas, Jean-Louis, Mazighi, Mikael, Mismetti, Patrick, Morange, Pierre-Emmanuel, Motte, Serge, Mullier, François, Nathan, Nathalie, Nguyen, Philippe, Ozier, Yves, Pernod, Gilles, Rosencher, Nadia, Roullet, Stéphanie, Roy, Pierre-Marie, Samama, Charles Marc, Schlumberger, Sylvie, Schved, Jean-François, Sié, Pierre, Steib, Annick, Susen, Sophie, van Belle, Eric, Van der Linden, Philippe, Vincentelli, André, Zufferey, Paul, and Garrigue, Delphine

Published
2018
Full Text
View/download PDF

33. Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie-réanimation (SFAR)

Author

Godier, Anne, Fontana, Pierre, Motte, Serge, Steib, Annick, Bonhomme, Fanny, Schlumberger, Sylvie, Lecompte, Thomas, Rosencher, Nadia, Susen, Sophie, Vincentelli, André, Gruel, Yves, Albaladejo, Pierre, and Collet, Jean-Philippe

Published
2018
Full Text
View/download PDF

34. Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)

Author

Albaladejo, P., Belisle, S., Blais, N., Bonhomme, F., Borel-Derlon, A., Borg, J.Y., Bosson, J.-L., Cohen, A., Collet, J.-P., de Maistre, E., Faraoni, D., Fontana, P., Garrigue Huet, D., Godier, A., Gruel, Y., Guay, J., Hardy, J.F., Huet, Y., Ickx, B., Laporte, S., Lasne, D., Levy, J.H., Llau, J., Le Gal, G., Lecompte, T., Lessire, S., Longrois, D., Madi-Jebara, S., Marret, E., Mas, J.L., Mazighi, M., Mismetti, P., Morange, P.E., Motte, S., Mullier, F., Nathan, N., Nguyen, P., Ozier, Y., Pernod, G., Rosencher, N., Roullet, S., Roy, P.M., Samama, C.M., Schlumberger, S., Schved, J.F., Sié, P., Steib, A., Susen, S., van Belle, E., van Der Linden, P., Vincentelli, A., Zufferey, P., Godier, Anne, Fontana, Pierre, Motte, Serge, Steib, Annick, Bonhomme, Fanny, Schlumberger, Sylvie, Lecompte, Thomas, Rosencher, Nadia, Susen, Sophie, Vincentelli, André, Gruel, Yves, Albaladejo, Pierre, and Collet, Jean-Philippe

Published
2018
Full Text
View/download PDF

35. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016

Author

Albaladejo, Pierre, Pernod, Gilles, Godier, Anne, de Maistre, Emmanuel, Rosencher, Nadia, Mas, Jean Louis, Fontana, Pierre, Samama, Charles Marc, Steib, Annick, Schlumberger, Sylvie, Marret, Emmanuel, Roullet, Stéphanie, Susen, Sophie, Madi-Jebara, Samia, Nguyen, Philippe, Schved, Jean François, Bonhomme, Fanny, and Sié, Pierre

Published
2018
Full Text
View/download PDF

37. Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)

Author

Albaladejo, P., Belisle, S., Blais, N., Bonhomme, F., Borel-Derlon, A., Borg, J.Y., Bosson, J.-L., Cohen, A., Collet, J.-P., de Maistre, E., Faraoni, D., Fontana, P., Garrigue Huet, D., Godier, A., Gruel, Y., Guay, J., Hardy, J.F., Huet, Y., Ickx, B., Laporte, S., Lasne, D., Levy, J.H., Llau, J., Le Gal, G., Lecompte, T., Lessire, S., Longrois, D., Madi-Jebara, S., Marret, E., Mas, J.L., Mazighi, M., Mismetti, P., Morange, P.E., Motte, S., Mullier, F., Nathan, N., Nguyen, P., Ozier, Y., Pernod, G., Rosencher, N., Roullet, S., Roy, P.M., Samama, C.M., Schlumberger, S., Schved, J.F., Sié, P., Steib, A., Susen, S., van Belle, E., van Der Linden, P., Vincentelli, A., Zufferey, P., Godier, Anne, Fontana, Pierre, Motte, Serge, Steib, Annick, Bonhomme, Fanny, Schlumberger, Sylvie, Lecompte, Thomas, Rosencher, Nadia, Susen, Sophie, Vincentelli, André, Gruel, Yves, Albaladejo, Pierre, and Collet, Jean-Philippe

Published
2018
Full Text
View/download PDF

39. Operation and organisation of ambulatory surgery in France. Results of a nationwide survey; The OPERA study

Author

Albi, Aline, Bloc, Sebastien, Charriot, Marie-Paule, Compère, Vincent, Dadure, Christophe, Delaunay, Laurent, Dufeu, Nicolas, Fiani, Michel, Gaertner, Elisabeth, Lanz, Thomas, Sirieix, Didier, Sztark, François, Vialles, Nathalie, Beaussier, Marc, Albaladejo, Pierre, Sciard, Didier, Jouffroy, Laurent, Benhamou, Dan, Ecoffey, Claude, and Aubrun, Frederic

Published
2017
Full Text
View/download PDF

43. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015

Author

Albaladejo, Pierre, Bonhomme, Fanny, Blais, Normand, Collet, Jean-Philippe, Faraoni, David, Fontana, Pierre, Godier, Anne, Llau, Juan, Longrois, Dan, Marret, Emmanuel, Mismetti, Patrick, Rosencher, Nadia, Roullet, Stéphanie, Samama, Charles-Marc, Schved, Jean-François, Sié, Pierre, Steib, Annick, and Susen, Sophie

Published
2017
Full Text
View/download PDF

45. Gestion des anticoagulants oraux directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d’intérêt en hémostase périopératoire (GIHP) – septembre 2015

Author

Albaladejo, Pierre, Bonhomme, Fanny, Blais, Normand, Collet, Jean Philippe, Faraoni, David, Fontana, Pierre, Godier, Anne, Llau, Juan V., Longrois, Dan, Marret, Emmanuel, Mismetti, Patrick, Rosencher, Nadia, Roullet, Stéphanie, Samama, Charles Marc, Schved, Jean-François, Sie, Pierre, Steib, Annick, and Susen, Sophie

Published
2016
Full Text
View/download PDF

47. Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care

Author

Kietaibl, Sibylle, primary, Ahmed, Aamer, additional, Afshari, Arash, additional, Albaladejo, Pierre, additional, Aldecoa, Cesar, additional, Barauskas, Giedrius, additional, De Robertis, Edoardo, additional, Faraoni, David, additional, Filipescu, Daniela C., additional, Fries, Dietmar, additional, Godier, Anne, additional, Haas, Thorsten, additional, Jacob, Matthias, additional, Lancé, Marcus D., additional, Llau, Juan V., additional, Meier, Jens, additional, Molnar, Zsolt, additional, Mora, Lidia, additional, Rahe-Meyer, Niels, additional, Samama, Charles M., additional, Scarlatescu, Ecaterina, additional, Schlimp, Christoph, additional, Wikkelsø, Anne J., additional, and Zacharowski, Kai, additional

Published
2023
Full Text
View/download PDF

48. Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

Author

Milling, Jr Tuman J., Middeldorp, S., Xu, Lizhen, Koch, Bruce, Demchuk, A.M., Eikelboom, J.W., Albaladejo, Pierre, Connolly, S.J., Milling, Jr Tuman J., Middeldorp, S., Xu, Lizhen, Koch, Bruce, Demchuk, A.M., Eikelboom, J.W., Albaladejo, Pierre, and Connolly, S.J.

Abstract

Item does not contain fulltext

Published
2023

49. Management of severe peri-operative bleeding:Guidelines from the European Society of Anaesthesiology and Intensive Care: Second update 2022

Author

Kietaibl, Sibylle, Ahmed, Aamer, Afshari, Arash, Albaladejo, Pierre, Aldecoa, Cesar, Barauskas, Giedrius, De Robertis, Edoardo, Faraoni, David, Filipescu, Daniela C., Fries, Dietmar, Godier, Anne, Haas, Thorsten, Jacob, Matthias, Lancé, Marcus D., Llau, Juan V., Meier, Jens, Molnar, Zsolt, Mora, Lidia, Rahe-Meyer, Niels, Samama, Charles M., Scarlatescu, Ecaterina, Schlimp, Christoph, Wikkelsø, Anne J., Zacharowski, Kai, Kietaibl, Sibylle, Ahmed, Aamer, Afshari, Arash, Albaladejo, Pierre, Aldecoa, Cesar, Barauskas, Giedrius, De Robertis, Edoardo, Faraoni, David, Filipescu, Daniela C., Fries, Dietmar, Godier, Anne, Haas, Thorsten, Jacob, Matthias, Lancé, Marcus D., Llau, Juan V., Meier, Jens, Molnar, Zsolt, Mora, Lidia, Rahe-Meyer, Niels, Samama, Charles M., Scarlatescu, Ecaterina, Schlimp, Christoph, Wikkelsø, Anne J., and Zacharowski, Kai

Abstract

BACKGROUND Management of peri-operative bleeding is complex and involves multiple assessment tools and strategies to ensure optimal patient care with the goal of reducing morbidity and mortality. These updated guidelines from the European Society of Anaesthesiology and Intensive Care (ESAIC) aim to provide an evidence-based set of recommendations for healthcare professionals to help ensure improved clinical management. DESIGN A systematic literature search from 2015 to 2021 of several electronic databases was performed without language restrictions. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was used to assess the methodological quality of the included studies and to formulate recommendations. A Delphi methodology was used to prepare a clinical practice guideline. RESULTS These searches identified 137 999 articles. All articles were assessed, and the existing 2017 guidelines were revised to incorporate new evidence. Sixteen recommendations derived from the systematic literature search, and four clinical guidances retained from previous ESAIC guidelines were formulated. Using the Delphi process on 253 sentences of guidance, strong consensus (>90% agreement) was achieved in 97% and consensus (75 to 90% agreement) in 3%. DISCUSSION Peri-operative bleeding management encompasses the patient's journey from the pre-operative state through the postoperative period. Along this journey, many features of the patient's pre-operative coagulation status, underlying comorbidities, general health and the procedures that they are undergoing need to be taken into account. Due to the many important aspects in peri-operative nontrauma bleeding management, guidance as to how best approach and treat each individual patient are key. Understanding which therapeutic approaches are most valuable at each timepoint can only enhance patient care, ensuring the best outcomes by reducing blood loss and, therefore, o, BACKGROUNDManagement of peri-operative bleeding is complex and involves multiple assessment tools and strategies to ensure optimal patient care with the goal of reducing morbidity and mortality. These updated guidelines from the European Society of Anaesthesiology and Intensive Care (ESAIC) aim to provide an evidence-based set of recommendations for healthcare professionals to help ensure improved clinical management.DESIGNA systematic literature search from 2015 to 2021 of several electronic databases was performed without language restrictions. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was used to assess the methodological quality of the included studies and to formulate recommendations. A Delphi methodology was used to prepare a clinical practice guideline.RESULTSThese searches identified 137999 articles. All articles were assessed, and the existing 2017 guidelines were revised to incorporate new evidence. Sixteen recommendations derived from the systematic literature search, and four clinical guidances retained from previous ESAIC guidelines were formulated. Using the Delphi process on 253 sentences of guidance, strong consensus (>90% agreement) was achieved in 97% and consensus (75 to 90% agreement) in 3%.DISCUSSIONPeri-operative bleeding management encompasses the patient's journey from the pre-operative state through the postoperative period. Along this journey, many features of the patient's pre-operative coagulation status, underlying comorbidities, general health and the procedures that they are undergoing need to be taken into account. Due to the many important aspects in peri-operative nontrauma bleeding management, guidance as to how best approach and treat each individual patient are key. Understanding which therapeutic approaches are most valuable at each timepoint can only enhance patient care, ensuring the best outcomes by reducing blood loss and, therefore, overall morbidity and mortality.CONCLUSIONAll healthc

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results